InvestorsHub Logo
Followers 120
Posts 9122
Boards Moderated 0
Alias Born 07/17/2005

Re: xoc post# 200580

Sunday, 09/13/2020 7:43:18 AM

Sunday, September 13, 2020 7:43:18 AM

Post# of 205093
With Mark continuing to work at the lab, it would seem only logical that they would continue to be actively focusing on Covid-19 testing and hopefully continuing their other businesses at the same time. If they are working on the RADx Initiative with the NIH, that would be a very good thing, but we can’t know for sure.

The NIH has been purchasing equipment and supplies from Arrayit for many years. In fact, ARYC installed their proprietary microarray platform at the NIH and trained personnel there. The NIH may have been using ARYC’s equipment and supplies in their efforts to fight the pandemic. High throughput has always been an advantage of ARYC’s technology.

As a CLIA certified lab, it dawned on me that they could be developing brand new methods of testing for antibodies as well as active disease. In the beginning, I think Mark said they had a Covid-19 test and did not specify it as an antibody test. I’ve always wondered about that. Can Arrayit do both?

“The NIH purchases Arrayit microarray instruments, hardware, software, reagents and consumable products. Arrayit offers a competitive advantage over other companies by combining speed, sensitivity, flexibility and cost-effectiveness in a single cytokine detection platform.”

https://search.nih.gov/search?utf8=%E2%9C%93&affiliate=nih&query=Arrayit&commit=Search

https://www.news-medical.net/news/20100921/Arrayit-installs-microarray-platform-at-NIH.aspx